BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25744017)

  • 1. A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in SIMPLICITY HTN-3.
    Middlekauff HR
    J Am Coll Cardiol; 2015 Mar; 65(9):959. PubMed ID: 25744017
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in SIMPLICITY HTN-3.
    Bakris GL; Bhatt DL
    J Am Coll Cardiol; 2015 Mar; 65(9):959-60. PubMed ID: 25744018
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
    Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal denervation for resistant hypertension: not dead yet.
    Reddy VY; Olin JW
    J Am Coll Cardiol; 2014 Sep; 64(11):1088-91. PubMed ID: 25212641
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of renal denervation with a standard EP catheter in the 24-h ambulatory blood pressure monitoring-long-term follow-up.
    Prochnau D; Figulla HR; Surber R
    Int J Cardiol; 2012 Jun; 157(3):447-8. PubMed ID: 22552169
    [No Abstract]   [Full Text] [Related]  

  • 6. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
    Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal denervation 2013].
    Spinar J; Vítovec J; Spinarová L
    Vnitr Lek; 2013 Aug; 59(8):724-9. PubMed ID: 24007231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal artery denervation for treating refractory hypertension].
    Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
    Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Denervation: Is It Ready for Prime Time?
    Lauder L; Wolf MA; Scholz SS; Hohl M; Mahfoud F; Böhm M
    Curr Cardiol Rep; 2019 Jul; 21(8):80. PubMed ID: 31278490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study.
    Sievert H; Schofer J; Ormiston J; Hoppe UC; Meredith IT; Walters DL; Azizi M; Diaz-Cartelle J; Cohen-Mazor M
    EuroIntervention; 2015 Feb; 10(10):1213-20. PubMed ID: 25452197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal sympathetic denervation for resistant hypertension.
    O'Brien E
    Lancet; 2009 Jun; 373(9681):2109; author reply 2109-10. PubMed ID: 19541031
    [No Abstract]   [Full Text] [Related]  

  • 12. Treating Hypertension Using Renal Artery Denervation: Problems and Progress.
    Townsend RR
    Adv Chronic Kidney Dis; 2019 Mar; 26(2):117-121. PubMed ID: 31023445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal denervation: one step backwards, three steps forward.
    Schlaich MP; Bakris GL
    Nat Rev Nephrol; 2018 Oct; 14(10):602-604. PubMed ID: 29980772
    [No Abstract]   [Full Text] [Related]  

  • 14. Percutaneous renal sympathetic denervation: 2013 and beyond.
    Froeschl M; Hadziomerovic A; Ruzicka M
    Can J Cardiol; 2014 Jan; 30(1):64-74. PubMed ID: 24365191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal denervation in hypertensive patients not on blood pressure lowering drugs.
    De Jager RL; Sanders MF; Bots ML; Lobo MD; Ewen S; Beeftink MM; Böhm M; Daemen J; Dörr O; Hering D; Mahfoud F; Nef H; Ott C; Saxena M; Schmieder RE; Schlaich MP; Spiering W; Tonino PA; Verloop WL; Vink EE; Vonken EJ; Voskuil M; Worthley SG; Blankestijn PJ
    Clin Res Cardiol; 2016 Sep; 105(9):755-62. PubMed ID: 27105858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal denervation for uncontrolled hypertension: critical review of the evidence.
    Chen C; Upadhyay A
    Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):114-122. PubMed ID: 27922849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial.
    Fengler K; Heinemann D; Okon T; Röhnert K; Stiermaier T; von Röder M; Besler C; Müller U; Höllriegel R; Schuler G; Desch S; Lurz P
    Clin Res Cardiol; 2016 Jul; 105(7):592-600. PubMed ID: 26728060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From SYMPLICITY HTN-3 to the renal denervation global registry: where do we stand and where should we go?
    Pathak A; Ewen S; Fajadet J; Honton B; Mahfoud F; Marco J; Schlaich M; Schmieder R; Tsioufis K; Ukena C; Zeller T
    EuroIntervention; 2014 May; 10(1):21-3. PubMed ID: 24832632
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Artery Denervation in Resistant Hypertension: The Good, The Bad and The Future.
    Al Raisi SI; Pouliopoulos J; Swinnen J; Thiagalingam A; Kovoor P
    Heart Lung Circ; 2020 Jan; 29(1):94-101. PubMed ID: 31327701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.